Clinical trials are research studies that test new and promising treatments directly with patients. In fact, today’s gold standard treatment options were once studies in a clinical trial. These studies may also test new ways to prevent or diagnose diseases such as lung cancer. Clinical trials may include new ways to take medicine, radiation therapy, or surgery. Clinical trial teams make sure you receive the safest and best care. If you are recently diagnosed, you do not need to wait to consider a clinical trial for your treatment. No matter where you are in your treatment process, a clinical trial could be a good option for you.
You do not need to be a doctor to understand your tumor. Biomarker testing can help.
When your doctors suspected you had cancer, they took a small portion of your tumor tissue (a biopsy) to have it examined. A specialist, called a pathologist, looked at your tumor cells under the microscope and found out you had lung cancer. There are two main types of lung cancer–small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). If you have NSCLC, the pathologist looks closely at the cancer cells for certain characteristics (features or qualities). Tumors with similar characteristics are referred to as subtypes. Adenocarcinoma (A-deh-noh-KAR-sih-NOH-muh) and squamous cell carcinoma (SKWAY-mus sel KAR-sih-NOH-muh) are the most common subtypes of NSCLC. Once your health care team knows the subtype of your cancer, treatment planning can begin. Read more & download your copy at LCRF.org/biomarkers.